Page last updated: 2024-10-24

candesartan cilexetil and Autoimmune Diseases

candesartan cilexetil has been researched along with Autoimmune Diseases in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research Excerpts

ExcerptRelevanceReference
"We examined effects of an angiotensin-II receptor blockers, candesartan cilexetil, in rats with dilated cardiomyopathy after autoimmune myocarditis."3.73Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy. ( Aizawa, Y; Inoue, M; Kashimura, T; Kodama, M; Ma, M; Saito, Y; Shirai, K; Suresh, PS; Tachikawa, H; Wahed, MI; Watanabe, K, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arumugam, S1
Thandavarayan, RA1
Palaniyandi, SS1
Giridharan, VV1
Arozal, W1
Sari, FR1
Soetikno, V1
Harima, M1
Suzuki, K1
Kodama, M2
Watanabe, K2
Shirai, K1
Ma, M1
Wahed, MI1
Inoue, M1
Saito, Y1
Suresh, PS1
Kashimura, T1
Tachikawa, H1
Aizawa, Y1

Other Studies

2 other studies available for candesartan cilexetil and Autoimmune Diseases

ArticleYear
Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: involvement of ACE2-Ang (1-7)-mas axis.
    Toxicology, 2012, Jan-27, Volume: 291, Issue:1-3

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzym

2012
Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
    Molecular and cellular biochemistry, 2005, Volume: 269, Issue:1-2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoimmune Diseases; Benzimidazoles; Biph

2005